The effect of anemia on the efficacy and safety of treating chronic hepatitis C infection with direct-acting antivirals in patients with chronic kidney disease-Reference-Cited by-同舟云学术

The effect of anemia on the efficacy and safety of treating chronic hepatitis C infection with direct-acting antivirals in patients with chronic kidney disease

Published:2020-10-27 Issue:4 Volume:53 Page:749-761
ISSN:0301-1623
Container-title:International Urology and Nephrology
language:en
Short-container-title:Int Urol Nephrol

Author:

Elmowafy Ahmed Yahia,Abbas Mohamed Hamed,Denewar Ahmed Abdelfattah,Mashaly Mohamed Elsayed,Shiha Gamal,El Wasif Salwa Mahmoud,Rostaing Lionel^ORCID,Bakr Mohamed Adel

Publisher

Springer Science and Business Media LLC

Subject

Urology,Nephrology

Link

https://link.springer.com/content/pdf/10.1007/s11255-020-02656-y.pdf

Reference46 articles.

1. Azmi AN, Tan SS, Mohamed R (2015) Hepatitis C and kidney disease: an overview and approach to management. World J Hepatol 7:78–92. https://doi.org/10.4254/wjh.v7.i1.78

2. Molnar MZ, Alhourani HM, Wall BM, Lu JL, Streja E, Kalantar-Zadeh K, Kovesdy CP (2015) Association of hepatitis C viral infection with incidence and progression of chronic kidney disease in a large cohort of US veterans. Hepatology 61:1495–1502. https://doi.org/10.1002/hep.27664

3. Fabrizi F, Dixit V, Messa P (2019) Hepatitis C virus and mortality among patients on dialysis: a systematic review and meta-analysis. Clin Res Hepatol Gastroenterol 43:244–254. https://doi.org/10.1016/j.clinre.2018.10.009

4. Fabrizi F, Dixit V, Messa P (2012) Impact of hepatitis C on survival in dialysis patients: a link with cardiovascular mortality? J Viral Hepat 19:601–607. https://doi.org/10.1111/j.1365-2893.2012.01633.x

5. Cox-North P, Hawkins KL, Rossiter ST, Hawley MN, Bhattacharya R, Landis CS (2017) Sofosbuvir-based regimens for the treatment of chronic hepatitis C in severe renal dysfunction. Hepatol Commun 1:248–255. https://doi.org/10.1002/hep4.1035

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Review of Direct-Acting Antivirals for Hepatitis C in Advanced CKD;Kidney International Reports;2023-02

2. KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease;Kidney International;2022-12

3. Safety and effectiveness of direct-acting antivirals in patients with chronic hepatitis C and chronic kidney disease;The Korean Journal of Internal Medicine;2022-09-01

4. Determination of Risk Factors Associated with the Failure of 12 Weeks of Direct-Acting Antiviral Therapy in Patients with Hepatitis C: A Prospective Study;BioMed Research International;2022-05-06

5. Daclatasvir/sofosbuvir/ribavirin;Reactions Weekly;2021-06